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'Who wills, can. Who tries, does. Who loves, lives'
 -Anne McCaffrey
  ASGO was initiated in Seoul on November 27, 2008, aimed 
at scientific exchange, international collaboration, provision 
of educational opportunities, deepening friendship between 
members, and ultimately improvement of Asian women’s 
health.
  Historically, ASGO originated from a small regional society; 
the Japan-Korean Joint Conference of Gynecologic Oncology 
Group (JKGOG), which was organized at the 9th Biennial 
International Gynecologic Cancer Society (IGCS) in Seoul.1 
During this annual meeting, gynecologic oncologists from 
these two countries acknowledged the importance of in-
creased regional cooperation, and envisioned the necessity of 
a representative society which could encompass the whole of 
the Asian continent. The time to realize this dream has not 
taken long.
  In fact, Asian women differ from non-Asians with respect to 
genetic background, disease presentation, and especially, so-
cio-cultural environment. However, most clinical practices 
have been sourced from the studies in western patients. In ad-
dition, a large proportion of global burden of gynecologic can-
cer still remains across the Asian area. According to the 
GLOBOCAN 2002, 44.9% of cancer cases occurred and 49.9% 
of cancer deaths were observed in Asia.2 For example, with 
493,100 new cases per year, cervical cancer is the second most 
common cancer among women, and the cause of 273,449 can-
cer deaths in the world. Among them, 265,744 new cases and 
142,679 cancer mortalities were observed in Asia.3 Epidemio-
logic and gyneco-oncologic reports from Japan, Korea, China, 
India, Indonesia, Philippines and Thailand also have demon-
strated the considerable burden of gynecologic cancers in 
their own countries.4-10 However, there is an increasing num-
ber of women suffering from cancer, because under-ascertain-
ment of elderly cases is well-known, especially in developing 
countries.11
  Because of these reasons and needs, the Asian Society of 
Gynecologic Oncology plays an essential role in under-
standing, investigating, and resolving regional health prob-
lems like other regional societies such as the Society of 
Gynecologic Oncologists (SGO) and the European Society of 
Gynecologic Oncology (ESGO).
  At the present time, ASGO has just been initiated with the 
passionate collaboration and warm friendship between all 
Asian countries (Fig. 1). We are all convinced that ASGO 
should be act as a central platform for embarking on the long 
voyage for the improvement of Asian women’s health. I be-
lieve in the words of ‘Who wills, can. Who tries, does. Who loves, 
lives’. This is the time of care and love for the healthy growing 
of ASGO.
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Fig. 1. Photo from the 1st council 
meeting of the ASGO, held in 
Seoul on June 25-26, 2009.
10. Wilailak S. Epidemiologic report of gynecologic cancer in 
Thailand. J Gynecol Oncol 2009; 20: 81-3.
11. Fallah M, Kharazmi E. Substantial under-estimation in cancer 
incidence estimates for developing countries due to under-as-
certainment in elderly cancer cases. Cancer Lett 2008; 264: 
250-5.
